3C Company, Inc. Newsroom - Profile and News Archive
3C Company, Inc. | Clintelligence solution, Business Performance Optimization, strategic business advantage for its pharmaceutical, biotechnology and medical device clients, 3C Company, Peter Oudheusden, business intelligence, BI implementation, pharma, Research and Development, Karen Briegs
Engage with 3C Company, Inc.
Follow:
Press Releases from 3C Company, Inc. :
Drug Development Costs Exceed $802 Million: Global Pharmas Use Clintelligence to Do Something About It
KENILWORTH, N.J. – May 2, 2007 (SEND2PRESS NEWSWIRE) — 3C Company, Inc., a leading provider of Business Performance Optimization (BPO) solutions to the Life Sciences Industry, announced today that it has aligned with yet another Global Pharmaceutical Firm to implement Clintelligence – 3C Company’s Business Intelligence Solution for strategic and tactical oversight of their Research and Development portfolio.